Related Experiment Video

Updated: Jan 13, 2026

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
11:47

A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders

Published on: June 8, 2014

12.1K

The crosstalk network of non-coding RNAs: Emerging opportunities for the clinical application of osteoporosis

Chunlu Yan1, Qiao Wan2, Zeling Fang2

  • 1The National Institute of Dunhuang Medicine, Gansu University of Chinese Medicine, Lanzhou, 730000, Gansu, PR China.

Non-Coding RNA Research
|January 8, 2026
PubMed

Insights

Extracellular vesicles (EVs) carrying non-coding RNAs (ncRNAs) show promise for early osteoporosis detection and targeted therapies. Further research is needed to overcome challenges for clinical application of this EV-ncRNA network.

Area of Science:

  • Biomedical Science
  • Molecular Biology
  • Cell Biology

Background:

  • Current bone density testing methods fail to detect early bone loss.
  • Existing osteoporosis therapies have limited efficacy and safety profiles.
  • There is a critical need for improved diagnostic tools and novel treatments for osteoporosis.

Purpose of the Study:

  • To review the role of extracellular vesicle (EV)-mediated non-coding RNA (ncRNA) interaction networks in bone metabolism.
  • To highlight the potential of EVs and ncRNAs for early osteoporosis diagnosis and targeted therapy.
  • To discuss the mechanisms of EV-ncRNA regulation in bone cells and their clinical translation prospects.

Main Methods:

  • Literature review focusing on extracellular vesicles (EVs) and non-coding RNAs (ncRNAs) in bone biology.
  • Analysis of mechanisms by which EVs carrying ncRNAs (miRNAs, lncRNAs, circRNAs) regulate osteoblasts and osteoclasts.
  • Evaluation of the clinical translation potential of EV-ncRNA networks for osteoporosis.

Main Results:

  • EVs serve as crucial carriers for various ncRNAs, establishing complex regulatory networks among bone cells.
  • EV-mediated ncRNA interactions are implicated in the regulation of osteoblast and osteoclast activity.
  • The EV-ncRNA network demonstrates potential for both early detection of bone loss and targeted osteoporosis therapy.

Conclusions:

  • EV-mediated ncRNA networks offer a promising avenue for precise diagnosis and targeted treatment of osteoporosis.
  • Further large-scale studies are essential to address specificity and clinical application challenges.
  • Rigorous investigation is required to fully realize the therapeutic and diagnostic potential of EVs in bone health.
Keywords:
Clinical applicationExtracellular vesiclesNetwork regulationOsteoporosisncRNA

More Related Videos

Osteoclast Derivation from Mouse Bone Marrow06:17

Osteoclast Derivation from Mouse Bone Marrow

Published on: November 6, 2014

24.8K
A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation09:37

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of mTORC1 in Osteoclast Formation

Published on: March 15, 2018

14.2K

Related Concept Videos

Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.9K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.7K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.8K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.5K
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
2.3K
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.0K